Transcriptional response pathways in a yeast strain sensitive to saframycin A and a more potent analog: Evidence for a common basis of activity

Chemistry and Biology

Volumn 9, Issue 5, 2002, Pages 607-618

  Plowright, Alleyn T ^a   Schaus, Scott E ^a   Myers, Andrew G ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; ACETYL COENZYME A; FATTY ACID; FUNGAL DNA; FUNGAL PROTEIN; ISOQUINOLINE DERIVATIVE; QUINALDIC ACID; QUINOLINE DERIVATIVE; RAPAMYCIN; SAFRAMYCIN A; TETRAHYDROISOQUINOLINE DERIVATIVE; TRABECTEDIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; DNA DAMAGE; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GENOME; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; OXIDATIVE STRESS; SACCHAROMYCES CEREVISIAE; STRUCTURE ACTIVITY RELATION;

ACETYL COENZYME A; DIOXOLES; DNA DAMAGE; DNA, FUNGAL; FATTY ACIDS; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, FUNGAL; GENOME, FUNGAL; HUMANS; ISOQUINOLINES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; QUINOLINES; SACCHAROMYCES CEREVISIAE; SIROLIMUS; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROISOQUINOLINES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036015848     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(02)00137-0     Document Type: Article

References (61)

1. New antibiotics, saframycins A, B, C, D and E
2. The structure of a novel antitumor antibiotic, saframycin A
3. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C
4. Mode of action of saframycin A, a novel heterocyclic quinone antibiotic. Inhibition of RNA synthesis in vivo and in vitro
5. Structure-activity relationships of saframycins
6. 14C]cyanide
7. Molecular mechanisms of binding and single- strand scission of deoxyribonucleic acid by the antitumor antibiotics saframycins A and C
8. Mode of action of saframycin antitumor antibiotics: Sequence selectivities in the covalent binding of saframycins A and S to deoxyribonucleic acid
9. DNA sequence selectivities in the covalent bonding of antibiotic saframycins Mx1, Mx3, A, and S deduced from MPE•Fe(II) footprinting and exonuclease III stop assays
10. 2
11. Bioactive compounds from aquatic and terrestrial sources
12. Ecteinascidins: Putative biosynthetic precursors and absolute stereochemistry
13. In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (Et-743, NSC-648766) against human tumors explanted from patients
14. Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts
15. Ecteinascidin-743: A marine-derived compound in advanced, pretreated sarcoma patients - Preliminary evidence of activity
16. Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies
17. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinate
18. Mechanism for the catalytic activation of ecteinascidin 743 and its subsequent alkylation of guanine N2
19. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation
20. Interference of transcriptional activation by the antineoplastic drug ecteinascidin 743
21. Increased DNA binding specificity for antitumor ecteinascidin 743 through protein-DNA interactions?
22. Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide excision-repair
23. The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent
24. Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743
25. Antitumor activity- and gene expression-based profiling of ecteinascidin Et 743 and phthalascidin Pt 650
26. A concise, stereocontrolled synthesis of (-)-saframycin A by the directed condensation of α-amino aldehyde precursors
27. Synthesis and evaluation of bishydroquinone derivatives of (-)-saframycin A: Identification of a versatile molecular template imparting potent antiproliferative activity
28. Exploring the metabolic and genetic control of gene expression on a genomic scale
29. Yeast microarrays for genome wide parallel genetic and gene expression analysis
30. Genome-wide expression monitoring in Saccharomyces cerevisiae
31. Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins
32. Genomewide studies of histone deacetylase function in yeast
33. Gene transcription analysis of S. cerevisiae exposed to neocarzinostatin protein chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure
34. Drug target validation and identification of secondary drug target effects using DNA microarrays
35. Genome-wide expression patterns in Saccharomyces cerevisiae: Comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol
36. Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae
37. Mutations in LIS1 (ERG6) gene confer increased sodium and lithium uptake in Saccharomyces cerevisiae
38. Yeast multidrug resistance: The PDR network
39. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hydridization
40. Hrp1, a sequence-specific RNA-binding protein that shuttles between the nucleus and the cytoplasm, is required for mRNA 3′-end formation in yeast
41. Saccharomyces cerevisiae SSB1 protein and its relationship to nucleolar RNA-binding proteins
42. Starting up yeast glycolysis
43. A yeast phosphofructokinase insensitive to the allosteric activator fructose 2, 6-bisphosphate
44. 2stimulon in Saccharomyces cerevisiae
45. In vivo function of the proteosome in the ubiquitin pathway
46. Ubiquitin-dependent protein degradation
47. Genetic and phenotypic overlap between autophagy and the cytoplasm to vacuole protein targeting pathway
48. Structure and function of the yeast vacuole and its role in autophagy
49. Aut2p and Aut7p, two novel microtubule-associated proteins are essential for delivery of autophagic vesicles to the vacuole
50. Cytosolic Hsp70s are involved in the transport of aminopeptidase I from the cytoplasm into the vacuole
51. +- ATPase
52. Stress-controlled transcription factors, stress-induced genes and stress tolerance in budding yeast
53. Remodeling the yeast genome expression in response to environmental changes
54. Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove
55. Purification of ribonucleotide reductase subunits Y1, Y2, Y3, and Y4 from yeast: Y4 plays a key role in diiron cluster assembly
56. Cell-cycle regulation of yeast histone mRNA